1,124
Views
33
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Clinicopathologic features and outcomes of lymphoplasmacytic lymphoma patients with monoclonal IgG or IgA paraprotein expression

, , , , , , , , , , , , & show all
Pages 1104-1113 | Received 23 Jul 2015, Accepted 16 Sep 2015, Published online: 23 Dec 2015

References

  • Swerdlow SH, Berger F, Pileri SA, et al. Lymphoplasmacytic lymphoma. In: Swerdlow SH, Campo E, Harris NL et al, editors. WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. Lyon, France: IARC; 2008. p 194–195.
  • Owen RG, Treon SP, Al-Katib A, et al. Clinicopathological definition of Waldenström's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenström's macroglobulinemia. Semin Oncol 2003; 30: 110–115.
  • Anderson KC, Alsina M, Bensinger W, et al. NCCN (National Comprehensive Cancer Network). Waldenström’s macroglobulinemia/lymphoplasmacytic lymphoma, version 1. 2015. Available from: http://www.nccn.org/professionals/physician_gls/f_guidelines_nojava.asp. Accessed on May 23, 2015.
  • Chakraborty R, Kapoor P, Ansell SM, et al. Ibrutinib for the treatment of Waldenström macroglobulinemia. Expert Rev Hematol 2015; 8: 569–579.
  • Konoplev S, Medeiros LJ, Bueso-Ramos CE, et al. Immunophenotypicprofile of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. Am J Clin Pathol 2005; 124: 414–420.
  • Dimopoulos MA, Kastritis E, Owen RG, et al. Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus. Blood 2014; 124: 1404–1411.
  • Tarella C, Arcaini L, Baldini L, et al. Italian Society of Hematology, Italian Society of Experimental Hematology, and Italian Group for Bone Marrow Transplantation Guidelines for the management of indolent, nonfollicular B-cell lymphoma (Marginal zone, lymphoplasmacytic, and small lymphocytic lymphoma). Clin Lymphoma Myeloma Leuk 2015; 15: 75–85.
  • Kobayashi K, Yokote T, Hirata Y, et al. Two case reports of non-secretory [correction of non-secretary]-Ig types of lymphoplasmacytic lymphoma (LPL). Ann Hematol 2010; 89: 945–947.
  • Tursz T, Brouet JC, Flandrin G, et al. Clinical and pathologic features of Waldenström's macroglobulinemia in seven patients with serum monoclonal IgG or IgA. Am J Med 1977; 63: 499–502.
  • Manasanch EE, Braylan R, Stetler-Stevenson M, et al. Lack of MYD88 L265P in non-immunoglobulin M lymphoplasmacytic lymphoma. Leuk Lymphoma 2014; 55: 1402–1403.
  • Owen RG, Kyle RA, Stone MJ, et al. VIth International Workshop on Waldenström macroglobulinaemia. Response assessment in Waldenström macroglobulinaemia: update from the VIth International Workshop. Br J Haematol 2013; 160: 171–176.
  • Cao X, Ye Q, Orlowski RZ, et al. Waldenström macroglobulinemia with extramedullary involvement at initial diagnosis portends a poorer prognosis. J Hematol Oncol 2015; 8: 74–86.
  • Sekhar J, Sanfilippo K, Zhang Q, et al. Waldenström macroglobulinemia: a surveillance, epidemiology, and end results database review from 1988 to 2005. Leuk Lymphoma 2012; 53: 1625–1626.
  • Gertz MA. Waldenström macroglobulinemia: a review of therapy. Am J Hematol 2005; 79: 147–157.
  • Mansoor A, Medeiros LJ, Weber DM, et al. Cytogenetic findings in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. Chromosomal abnormalities are associated with the polymorphous subtype and an aggressive clinical course. Am J Clin Pathol 2001; 116: 543–549.
  • Monge J, Braggio E, Ansell SM. Genetic factors and pathogenesis of Waldenström’s macroglobulinemia. Curr Oncol Rep 2013; 15: 450–456.
  • Cook JR, Aguilera NI, Reshmi-Skarja S, et al. Lack of PAX5 rearrangements in lymphoplasmacytic lymphomas: reassessing the reported association with t(9;14). Hum Pathol 2004; 35: 447–454.
  • Ondrejka SL, Lin JJ, Warden DW, et al. MYD88 L265P somatic mutation: its usefulness in the differential diagnosis of bone marrow involvement by B-cell lymphoproliferative disorders. Am J Clin Pathol 2013; 140: 387–394.
  • Anelli L, Zagaria A, Minervini A, et al. IgG-lymphoplasmacytic lymphoma following polycythemia vera: JAK2 V617F and MYD88 L265P mutations separated in the same house. Ann Hematol 2014; 93: 1605–1607.
  • Treon SP, Xu L, Yang G, et al. MYD88 L265P somatic mutation in Waldenström’s macroglobulinemia. N Engl J Med 2012; 367: 826–833.
  • Chng WJ, Schop RF, Price-Troska T, et al. Gene-expression profiling of Waldenström macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma. Blood 2006; 108: 2755–2763.
  • Ocio EM, Schop RF, Gonzalez B, et al. 6q deletion in Waldenström macroglobulinemia is associated with features of adverse prognosis. Br J Haematol 2007; 136: 80–86.
  • Tsuji T, Yamasaki H, Arima N, et al. Lymphoplasmacytic lymphoma with a breast tumor and IgG + IgA type biclonalgammopathy. Rinsho Ketsueki 2009; 50: 309–312.
  • Iwanaga M, Yoshida Y, Tagawa M, et al. Waldenström’s macroglobulinemia in a 10-year stable IgG monoclonal gammopathy of undetermined significance. Leukemia Res 2009; 33: 193–195.
  • Sahin I, Leblebjian H, Treon SP, et al. Waldenström macroglobulinemia: from biology to treatment. Expert Rev Hematol 2014; 7: 157–168.
  • Kyriakou E, Kolovou K, Kotsopoulou M, et al. IgG-lambda secreting B-lymphoplasmacytic lymphoma with disseminated cutaneous infiltration: report of a rare case. J BUON 2009; 14: 695–698.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.